Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2015-10-27 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
关于公司子公司收购美国尼普洛诊断有限公司股权相关事项构成关联交易的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a related-party transaction involving the company's subsidiary acquiring shares of a target company. It details the transaction overview, parties involved, strategic purpose, independent director opinions, and the need for shareholder approval. The document is titled as an "announcement" and is relatively short (4010 characters). It does not contain financial statements or detailed financial data but rather describes the transaction and related approvals. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement about a related-party transaction and not a full financial report or a capital/financing update per se. It is not a Capital/Financing Update (CAP) because it focuses on the related-party nature and approvals rather than just financing details. Therefore, the best classification is Regulatory Filings (RNS).
2015-10-27 Chinese
第二届监事会第二十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the 20th meeting of the second Supervisory Board of the company SanNuo Bio-sensing Co., Ltd. It details the approval of various proposals related to capital increases, equity acquisitions, bank credit applications, and related party guarantees. The document includes voting results and states that these proposals will be submitted to the company's 2015 second extraordinary general meeting for approval. The content is procedural and governance-related, focusing on supervisory board decisions and compliance with company law and regulations. It does not contain financial statements, earnings data, or detailed financial analysis. It is not a full annual or interim report, nor an earnings release or investor presentation. It is not a notice of dividend, share issue, or director dealing. The document is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement of supervisory board meeting resolutions and related corporate governance matters, without substantive financial data or report content.
2015-10-27 Chinese
关于使用超募资金对公司子公司增资并参与海外股权收购事宜的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the use of over-raised funds (超募资金) by the company to increase capital in its subsidiary and participate in an overseas equity acquisition. It details the background of the fundraising, approvals by the board and independent directors, and the strategic rationale for the investment. The document references regulatory compliance with Shenzhen Stock Exchange rules and includes opinions from the board, independent directors, supervisory board, and the sponsor institution. It is structured as a formal announcement to shareholders and the public about a specific capital use plan and related corporate actions, rather than a full financial report or earnings release. The document length is about 5,875 characters, which is sufficient for a detailed announcement but does not contain comprehensive financial statements or quarterly/yearly financial results. It is not a proxy solicitation, voting results, or management report. The content focuses on capital use and financing activities, specifically the use of over-raised funds for subsidiary capital increase and acquisition. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2015-10-27 Chinese
2015年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "2015 年第三季度报告全文" which translates to "2015 Third Quarter Report Full Text." It contains detailed financial data, including balance sheet items, profit and loss items, cash flow items, shareholder information, risk factors, management discussion and analysis, and fundraising project details. The presence of comprehensive financial statements and management discussion for a quarterly period clearly indicates this is a quarterly financial report. The length of the document (15,000 characters) and the detailed financial data confirm it is not a mere announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2015
2015-10-26 Chinese
关于调整董事会部分专门委员会委员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding changes in the composition of the company's board committees, specifically the nomination committee and the remuneration and assessment committee. It details resignations and appointments of board members and committee members. There is no financial data, no mention of annual or quarterly reports, no audit information, and no other types of filings. The content clearly fits the category of Board/Management Information, which covers announcements of changes in the company's board of directors or senior management.
2015-10-26 Chinese
第二届监事会第十九次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board regarding the approval of the company's 2015 third quarter report. It states that the Supervisory Board has reviewed and approved the 2015 Q3 report, confirming its accuracy and compliance with regulations. The document itself does not contain the full financial statements or detailed financial data of the quarterly report but rather announces the approval and directs readers to the full report published elsewhere. The document length is short (911 characters), and it serves as an announcement of the report rather than the report itself. According to the 'Menu vs Meal' rule, this should be classified as a Regulatory Filing (RNS) because it is an announcement related to a report, not the report itself.
2015-10-26 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.